U.S. drugmaker Pfizer pauses new studies due to coronavirus pandemic
March 25 (Reuters) - Pfizer Inc said on Wednesday it was delaying patient recruitment in new and ongoing global trials for three weeks due to the...
March 25 (Reuters) - Pfizer Inc said on Wednesday it was delaying patient recruitment in new and ongoing global trials for three weeks due to the...